PanCancerT

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

Swarm Oncology

This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.

Ypsilon Therapeutics

The company develops T-cell receptor mimic antibodies and bispecific T-cell engagers to treat patients with solid tumours, such as triple-negative breast and lung cancer.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

Zelluna

This company develops T cell receptor guided natural killer cell therapies to treat patients with solid cancers.

PACT Pharma

This biopharmaceutical company develops personalised and off-the-shelf gene-engineered T-cell therapies to treat patients with solid tumours.